A case of catatonia resembling frontotemporal dementia and resolved with electroconvulsive therapy.
We describe a case of catatonia in a 51-year-old man in whom the catatonic symptoms could not be distinguished from symptoms of frontotemporal dementia (FTD) until they were resolved with electroconvulsive therapy (ECT). When it is difficult to distinguish between catatonia and FTD in patients with frontal dysfunction associated with frontal lobe atrophy, we believe that sequential administration of benzodiazepines and ECT is important for therapeutic diagnosis because the risk of missing a diagnosis of catatonia outweighs the risks associated with administration of benzodiazepines and/or ECT.
Suzuki
Kazumasa
K
Takano
Takehisa
T
Matsuoka
Hiroo
H
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D000927:Anticonvulsants / Q000008:administration & dosage; D018692:Antimanic Agents / Q000627:therapeutic use; D001284:Atrophy / Q000175:diagnosis / Q000473:pathology; D001285:Atropine / Q000008:administration & dosage; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D002389:Catatonia / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D003937:Diagnosis, Differential; D004565:Electroconvulsive Therapy / Q000379:methods*; D005500:Follow-Up Studies; D005625:Frontal Lobe / Q000473:pathology; D057180:Frontotemporal Dementia / Q000175:diagnosis*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D009467:Neuromuscular Depolarizing Agents / Q000008:administration & dosage; D013390:Succinylcholine / Q000008:administration & dosage; D013874:Thiopental / Q000008:administration & dosage; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000927:Anticonvulsants; D018692:Antimanic Agents; D009467:Neuromuscular Depolarizing Agents; D014635:Valproic Acid; D001285:Atropine; D013390:Succinylcholine; D013874:Thiopental